Showing results (7241-7250 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|October 1, 2021
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case StudyDimitri Anzellini, Vitaliana DE Sanctis, Maurizio Valeriani, et al.Anticancer Research|October 1, 2021
Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenectomy for Pancreatic Adenocarcinoma: A Single-Center ExperienceHryhoriy Lapshyn, Theresa Schulte, Natalie Petruch, et al.Anticancer Research|October 1, 2021
Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective AnalysisTaiko Nakazawa, Yukiya Narita, Ryosuke Kumanishi, et al.Anticancer Research|October 1, 2021
Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent ChemoradiotherapyYung-Hsin Huang, Yu-Shin Hung, Cheng-Chou Lai, et al.Anticancer Research|October 1, 2021
Pancreaticoduodenectomy at a Non-high-volume Center and Efforts to Perform Safe SurgeryTaishi Yamane, Daisuke Izumi, Shotaro Kinoshita, et al.Anticancer Research|October 1, 2021
Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract CancerShozo Mori, Taku Aoki, Takayuki Shiraki, et al.Anticancer Research|January 30, 2022
Challenges of Surgical Resection of Carotid Body Tumors - Multiple Feeding Arteries and Preoperative EmbolizationKiyoto Shiga, Katsunori Katagiri, Aya Ikeda, et al.Anticancer Research|January 30, 2022
SBRT in Localized Renal Carcinoma: A Review of the LiteratureCarolina DE LA Pinta, Raquel García Latorre, Raquel FuentesAnticancer Research|January 30, 2022
The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast CancerChristine Song, Ayse Tuba Kendi, Val J Lowe, et al.Anticancer Research|January 30, 2022
CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal CancerToshiaki Hagiwara, Kiichi Sugimoto, Hirotaka Momose, et al.Pageof 2,589